Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
28/10/2021 1:28 pm
Bloodwork question about phosphatidylserine. Baseline, three years in, and the numbers moved in a direction I did not expect.
What the phospholipid class does pharmacologically does not require the subjective effect to be large to be real.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Interested in the methods more than the conclusion.
28/10/2021 3:02 pm
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation. Not on phosphatidylserine but the pattern is familiar.